Literature DB >> 27717042

Effects of melatonin on severe crush spinal cord injury-induced reactive astrocyte and scar formation.

Warin Krityakiarana1,2, Kamonrapat Sompup3, Nopporn Jongkamonwiwat4, Sujira Mukda3, Fernando Gomez Pinilla5, Piyarat Govitrapong3,6, Pansiri Phansuwan-Pujito7.   

Abstract

The present work aimed at analyzing the effects of melatonin on scar formation after spinal cord injury (SCI). Upregulation of reactive astrocyte under SCI pathological conditions has been presented in several studies. It has been proved that the crucial factor in triggering this upregulation is proinflammatory cytokines. Moreover, scar formation is an important barrier to axonal regeneration through the lesion area. Melatonin plays an important role in reducing inflammation, but its effects on scar formation in the injured spinal cord remain unknown. Hence, we used the model of severe crush injury in mice to investigate the effects of melatonin on scar formation. Mice were randomly separated into four groups; SCI, SCI+Melatonin 1 (single dose), SCI+Melatonin 14 (14 daily doses), and control. Melatonin was administered by intraperitoneal injection (10 mg/kg) after injury. Immunohistochemical analysis, Western blot, and behavioral evaluation were used to explore the effects of melatonin after SCI for 14 days. The melatonin-treated mice presented higher expression of neuronal markers (P < 0.001). Remarkably, the inflammatory response appeared to be greatly reduced in the SCI+Melatonin 14 group (P < 0.001), which also displayed less scar formation (P < 0.05). These findings suggest that melatonin inhibits scar formation by acting on inflammatory cytokines after SCI. Overall, our results suggest that melatonin is a promising treatment strategy after SCI that deserves further investigation.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  astrocytes; axonal regeneration; glial scar; inflammation; melatonin

Mesh:

Substances:

Year:  2016        PMID: 27717042     DOI: 10.1002/jnr.23930

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol.

Authors:  Rômulo Rodrigo de Souza Almeida; Larissa Daniele Bobermin; Belisa Parmeggiani; Krista Minéia Wartchow; Diogo Onofre Souza; Carlos-Alberto Gonçalves; Moacir Wajner; Guilhian Leipnitz; André Quincozes-Santos
Journal:  Amino Acids       Date:  2022-08-04       Impact factor: 3.789

Review 2.  Melatonin for the treatment of spinal cord injury.

Authors:  Yan Zhang; Wen-Xiu Zhang; Yan-Jun Zhang; Ya-Dong Liu; Zong-Jian Liu; Qi-Chao Wu; Yun Guan; Xue-Ming Chen
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

3.  The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review.

Authors:  Jianan Lu; Yujie Luo; Shuhao Mei; Yuanjian Fang; Jianmin Zhang; Sheng Chen
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

4.  Interleukin-10 genetically modified clinical-grade mesenchymal stromal cells markedly reinforced functional recovery after spinal cord injury via directing alternative activation of macrophages.

Authors:  Tianyun Gao; Feifei Huang; Wenqing Wang; Yuanyuan Xie; Bin Wang
Journal:  Cell Mol Biol Lett       Date:  2022-03-17       Impact factor: 5.787

5.  EphB2 knockdown decreases the formation of astroglial-fibrotic scars to promote nerve regeneration after spinal cord injury in rats.

Authors:  Jian Wu; Bing Lu; Riyun Yang; Ying Chen; Xue Chen; Yi Li
Journal:  CNS Neurosci Ther       Date:  2021-04-01       Impact factor: 5.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.